Physician profile

Reid Vaughn Graves

Urology · Saint Petersburg, FL

NPI 1164684239

$5,046.60

in general payments reported to CMS, 2019-2025

47 companies · $763 in 2025

The $763 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,271.78

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $684.90 2021-2025 Interstim, Gi Genius
Karl Storz Endoscopy-America $425.20 2020-2024 N.A., Tele Pack, Hopkins
Janssen Biotech, INC. $369.13 2019-2025 Erleada
Astellas Pharma US INC $298.55 2019-2023 Xtandi, Myrbetriq
Axonics, INC. $218.33 2020-2024 Axonics
Procept Biorobotics Corporation $198.09 2023-2025 Aquabeam Robotic System
Sumitomo Pharma America, INC. $197.96 2023-2025 Orgovyx
Valencia Technologies Corporation $196.46 2024 Ecoin Device Kit
Pfizer INC. $186.88 2019-2025
Boston Scientific Corporation $170.49 2019-2025 Spaceoar Vue System - 10ml, Axonics
Coloplast Corp $154.17 2019-2025 Speedicath
Endo Pharmaceuticals INC. $137.96 2019-2024 Xiaflex, Aveed, Edex
Abbvie INC. $136.30 2019-2025
Tolmar, INC. $118.26 2023-2025 Eligard
Urogen Pharma, INC. $115.42 2022-2025
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $110.61 2019-2025
Dendreon Pharmaceuticals LLC $108.24 2021-2025 Provenge
Teleflex LLC $102.32 2022-2024 Urolift
Laborie Medical Technologies Corp. $97.78 2022-2023
Zyla Life Sciences, INC. $79.07 2019
Merck Sharp & Dohme LLC $68.18 2024-2025 Keytruda, Welireg
Telix Pharmaceuticals $64.49 2023-2024 Illuccix
Intuitive Surgical, INC. $63.81 2024
Olympus America INC. $60.92 2023-2024 Itind System
Neotract INC. $59.85 2019
Novartis Pharmaceuticals Corporation $54.60 2023-2024
Endo USA, INC. $54.20 2025 Aveed, Xiaflex, Edex
Ferring Pharmaceuticals INC. $53.76 2019-2024 Adstiladrin
Accord Healthcare, INC. $39.17 2024-2025
Travere Therapeutics, INC. $38.52 2019
Immunitybio, INC. $38.33 2025
Blue Earth Diagnostics $37.96 2024
Antares Pharma, INC. $34.46 2019-2025 Xyosted
Medtronic USA, INC. $29.00 2020
Storz Medical America, INC. $27.65 2024
Ambu INC. $25.87 2025
Metuchen Pharmaceuticals $21.15 2019
Azurity Pharmaceuticals, INC. $20.63 2025 Azmiro
Myriad Genetic Laboratories, INC. $20.17 2022
Angiodynamics, INC. $17.52 2022
Urovant Sciences INC $17.43 2022
Baxter Healthcare $17.23 2019
Myovant Sciences INC. $16.73 2021
Sun Pharmaceutical Industries INC. $16.03 2021
Therapeuticsmd, INC. $15.97 2019
180 Medical, INC. $15.19 2019
Tolmar Pharmaceuticals, INC. $11.66 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Reid Vaughn Graves

$5,046.60

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $763 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/425029/reid-vaughn-graves

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.